Comparing metabolic network models based on genomic and automatically inferred enzyme information from Plasmodium and its human host to define drug targets in silico.

Plasmodium falciparum causes the most severe malaria pathogen and has developed resistance to existing drugs making it indispensable to discover new drugs. In order to predict drug targets in silico, a useful model for the metabolism is needed. However, automatically reconstructed network models typically cover more non-confirmed enzymes than confirmed enzymes of known gene products. Furthermore, it needs to be considered that the parasite takes advantage of the metabolism of the host. We compared several reconstructed network models and aimed to find the best suitable reconstruction for detecting drug targets in silico. We computationally reconstructed the metabolism based on automatically inferred enzymes and compared this with a reconstructed model that was based only on enzymes whose coding genes are known. Additionally, we tested if integrating enzymes of the host cell is beneficial for such an analysis. We employed several well established criteria for defining essential enzymes including chokepoints, betweenness centrality (or load-points), connectivity and the diameter of the networks. Comparing the modeling results with a comprehensive list of known drug targets for P. falciparum, showed that we had the best discovery success with a network model consisting only of enzymes from the parasite alone which coding genes were known.

[1]  中尾 光輝,et al.  KEGG(Kyoto Encyclopedia of Genes and Genomes)〔和文〕 (特集 ゲノム医学の現在と未来--基礎と臨床) -- (データベース) , 2000 .

[2]  R. Eils,et al.  Estimating novel potential drug targets of Plasmodium falciparum by analysing the metabolic network of knock-out strains in silico. , 2009, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

[3]  P. Karp,et al.  Computational prediction of human metabolic pathways from the complete human genome , 2004, Genome Biology.

[4]  D. Fell,et al.  The small world inside large metabolic networks , 2000, Proceedings of the Royal Society of London. Series B: Biological Sciences.

[5]  R. Altman,et al.  Computational analysis of Plasmodium falciparum metabolism: organizing genomic information to facilitate drug discovery. , 2004, Genome research.

[6]  Paul J Thornalley,et al.  Antimalarial activity in vitro of the glyoxalase I inhibitor diester, S-p-bromobenzylglutathione diethyl ester. , 1994, Biochemical pharmacology.

[7]  Marcus Oswald,et al.  Machine learning based analyses on metabolic networks supports high-throughput knockout screens , 2008, BMC Systems Biology.

[8]  F. Cohen,et al.  Expression profiling of the schizont and trophozoite stages of Plasmodium falciparum with a long-oligonucleotide microarray , 2003, Genome Biology.

[9]  H. Ginsburg.  Caveat emptor: limitations of the automated reconstruction of metabolic pathways in Plasmodium. , 2009, Trends in parasitology.

[10]  Matthew W. Hahn,et al.  Comparative genomics of centrality and essentiality in three eukaryotic protein-interaction networks. , 2005, Molecular biology and evolution.

[11]  Jonathan E. Allen,et al.  Sequence of Plasmodium falciparum chromosomes 2, 10, 11 and 14 , 2002, Nature.

[12]  U. Sauer,et al.  Systematic evaluation of objective functions for predicting intracellular fluxes in Escherichia coli , 2007, Molecular systems biology.

[13]  Dietmar Schomburg,et al.  Observing local and global properties of metabolic pathways: "load points" and "choke points" in the metabolic networks , 2006, Bioinform..

[14]  Massimo Marchiori,et al.  Error and attacktolerance of complex network s , 2004 .

[15]  Adam M. Feist,et al.  A genome-scale metabolic reconstruction for Escherichia coli K-12 MG1655 that accounts for 1260 ORFs and thermodynamic information , 2007, Molecular systems biology.

[16]  S. Shuto,et al.  New neplanocin analogues. 12. Alternative synthesis and antimalarial effect of (6'R)-6'-C-methylneplanocin A, a potent AdoHcy hydrolase inhibitor. , 2002, Journal of medicinal chemistry.

[17]  J. Pinney,et al.  metaSHARK: software for automated metabolic network prediction from DNA sequence and its application to the genomes of Plasmodium falciparum and Eimeria tenella , 2005, Nucleic acids research.

[18]  R. Snow,et al.  The past, present and future of childhood malaria mortality in Africa. , 2001, Trends in parasitology.

[19]  A. Barabasi,et al.  Network biology: understanding the cell's functional organization , 2004, Nature Reviews Genetics.

[20]  Gábor Csárdi,et al.  The igraph software package for complex network research , 2006 .

[21]  Ernesto Estrada.  Virtual identification of essential proteins within the protein interaction network of yeast , 2005, Proteomics.

[22]  Y. Kitade,et al.  Synthesis of S-adenosyl-L-homocysteine hydrolase inhibitors and their biological activities. , 1999, Nucleic acids symposium series.

[23]  Ozlem Keskin,et al.  Topological properties of protein interaction networks from a structural perspective. , 2008, Biochemical Society transactions.

[24]  R. Gwilliam,et al.  Sequence of Plasmodium falciparum chromosomes 1, 3–9 and 13 , 2002, Nature.

[25]  Ney Lemke,et al.  Towards the prediction of essential genes by integration of network topology, cellular localization and biological process information , 2009, BMC Bioinformatics.

[26]  J. Le bras,et al.  The mechanisms of resistance to antimalarial drugs in Plasmodium falciparum , 2003, Fundamental & clinical pharmacology.

[27]  Igor Jurisica,et al.  Functional topology in a network of protein interactions , 2004, Bioinform..

[28]  C. Ouzounis,et al.  Expansion of the BioCyc collection of pathway/genome databases to 160 genomes , 2005, Nucleic acids research.